key: cord-0269467-mvcapljp
authors: Zhang, W.; Martinez, M.; Davis, B. D.; Chen, S. S.; Sincuir Martinez, J.; Corona, C.; Diaz, G.; Makhoul, E.; Heneidi, S.; Goldberg, J.; Plummer, J. T.; Vail, E.
title: SARS-CoV-2 variant transmission in a community-health population (Mexico City, Mexico)
date: 2021-10-20
journal: nan
DOI: 10.1101/2021.10.18.21264783
sha: e7a0c13d314d95849fe51c576cf9ca20a4a7afb2
doc_id: 269467
cord_uid: mvcapljp

The SARS-CoV-2 variant, B.1.1.519, arose in North and Central America, circulating primarily in Mexico. We demonstrate that this variant peaked during the second wave of COVID-19 in Mexico City in the spring of 2021. This variant is likely more infectious, attributed to mutation in the RBD of the spike protein T478K also seen in the alpha variant (B.1.1.7). However the time dynamics of the spread of this variant drastically changed upon the introduction of delta (B.1.617.2) to the country in which we observe a shift from 0% in May 2021 to 55% delta in the span of one month. Since the delta variant has dominantly spread across the globe, we investigated the increasing frequency of the Mexico variant , B.1.1.519, in the public community within Mexico City. Once present, the delta variant was 78% of the Mexico City catchment in July 2021, a time which marked the commencement of Mexicos third wave. Our data supports the growing concern that the delta variant is closely associated with the massive infection spread of the VOC in Central and South America. While the T478K mutation, also seen in the alpha variant, has evidence for increased transmissibility, these data suggest that the delta variant shows overall increased fitness seeing as it outcompeted the B.1.1519 this Mexico community.

Assessing core genomic features of SARS-CoV-2 can be used for comparative analysis as a useful tool to track sources of transmission and SARS-Cov-2 evolution within communities and throughout the world (1) . Novel variants of SARS-CoV-2 including those seen in the UK (4) , India (delta and kappa) (5) and South America (lambda) (6) have emerged with the concern of increased infectivity and virulence (7, 8) . The rate of evolution of SARS-CoV-2 in 2020 from current estimates is approximately 24-25 substitutions per year (9) . With a growing rate of COVID cases, tracking these variants within countries becomes essential for evaluating variants that will rapidly displace other variants and predominate globally. We sought to track the local community spread within the Mexico City metropolitan area during the height of its second and third wave of COVID-19. By July 2021, Mexico entered its third wave of the SARS-CoV-2 pandemic with infections rising 29% compared to the previous week with over 20,000 new cases daily (11) . Historically, Mexico City has been highest, accounting for one third of the country's positive cases in the first and second wave (12) . With low vaccination rates (only 27% of the population fully vaccinated) and >95% of the hospitalized COVID-19 positive patients are unvaccinated (13) , understanding and tracking the emerging variants in this vulnerable population. Here we report the fitness of the delta variant All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

Appropriate regulatory review was completed by the CSMC Office of Research Compliance and Quality Improvement (IRB #629_MOD6887). Samples were collected by nasopharyngeal swabs from patients presenting COVID-19 like symptoms. Total nucleic acid was extracted using the QIAamp Viral RNA Mini Kit on the QIASymphony (Qiagen, Germantown, USA). Following the protocol from our previous study (14) , all patients were first assessed by RT-qPCR for SARS-CoV-2 viral RNA for N, E and RdRp gene expression. Samples were diagnostically COVID-19 positive with amplification of the targeted region crossing the threshold before 30 cycles. In total, 480 COVID-19 positive samples were used for parallel NGS analysis.

All samples were processed for NGS and phylogenetic analysis similar to Zhang et al., 2021. All sequencing reads were mapped to SARS-CoV-2 genome and analyzed using our previously established protocol (14, 15) . Data used in this study has been deposited to GISAID.

Phylogenetic analysis with CSMC cohort and a global subsampling was performed. At the time of publication, global SARS-CoV-2 clades were assigned based on pangolin designations and nomenclature based on WHO designations.

Results are presented by months and age demographics of the cohort. We conducted statistical analyses, including medians and paired t-tests.

Phylogenetic analysis of a public health community in Mexico city revealed a diverse set of lineages ( Figure 1 ). The largest proportion of individuals carried the B.1.1.519 variant most All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (12, 13) of their country's population being fully vaccinated, data from this study validate growing concerns that emerging variants such as delta plus and lambda which contain similar mutations to delta, will likely quickly overtake this relatively unprotected population. 

Novel SARS-CoV-2 variants: the pandemics within the pandemic

Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv

Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

SARS-CoV-2 Lambda variant exhibits higher infectivity and immune resistance

Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant

SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

CoV Genome Tracker: tracing genomic footprints of Covid-19 pandemic

Emergence and spread of the potential variant of interest (VOI) B.1.1.519 of SARS-CoV-2 predominantly present in Mexico

Worldometer -real time world statistics

Live): 84,382,650 Cases and 1,835,399 Deaths from COVID-19 Virus Pandemic -Worldometer

Covid World Vaccination Tracker -The New York Times

Analysis of Genomic Characteristics and Transmission Routes of Patients With Confirmed SARS-CoV-2 in Southern California During the Early Stage of the US COVID-19 Pandemic

Emergence of a Novel SARS-CoV-2 Variant in Southern California

Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta)

Delta coronavirus variant: scientists brace for impact

Delta variant: What is happening with transmission, hospital admissions, and restrictions? BMJ